Capital Midwest Fund

ProNAi

ProNAi Raises $12M Series C Financing To Expand Cancer Studies

The cancer drug developer ProNAi Therapeutics Inc. Monday announced the closing of a Series C preferred financing round of more than $12 million with existing and new investors.

WWJ Newsradio 950–01/13/2014

cytopherx

CytoPherx Raises $34M To Move Into U.S. Clinical Trials

CytoPherx Inc. announced it has completed a $34 million round of funding. The funds will be used to complete United States clinical trials and gain FDA approval to commercialize the CytoPherx anti-inflammatory therapy for acute kidney injury.

WWJ Newsradio 950–01/04/2012

Follow

Get every new post delivered to your Inbox.

Join 1,973 other followers